PMC:7228307 / 315-527 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7228307","sourcedb":"PMC","sourceid":"7228307","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7228307","text":" network of inflammatory host‐protective effector functions that are key to the normal physiology of immune resistance to pathogens. More than 100 therapeutic monoclonal antibodies (mAbs) are approved or in late ","tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":41,"end":49},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"},{"subj":"T3","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T2","span":{"begin":25,"end":29},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"},{"id":"T3","span":{"begin":50,"end":59},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"},{"id":"T4","span":{"begin":122,"end":131},"obj":"http://purl.obolibrary.org/obo/IDO_0000528"}],"attributes":[{"subj":"T2","pred":"source","obj":"LitCovid-sample-PD-IDO"},{"subj":"T3","pred":"source","obj":"LitCovid-sample-PD-IDO"},{"subj":"T4","pred":"source","obj":"LitCovid-sample-PD-IDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#ec93a2","default":true},{"id":"LitCovid-sample-PD-IDO","color":"#93bcec"}]}]}}